Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.
about
On the emergence of multifocal cancersRecurrent and multiple bladder tumors show conserved expression profilesA metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data.The origins of urothelial carcinoma.Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylationA strategy for distinguishing optimal cancer subtypes.Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract.COLD-PCR: improving the sensitivity of molecular diagnostics assays.The effect of intravesical chemotherapy in the prevention of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.Monoclonality of multifocal epithelioid hemangioendothelioma of the liver by analysis of WWTR1-CAMTA1 breakpoints.Epigenetic alterations in bladder cancer and their potential clinical implications.Epidermal Growth Factor Receptor and Ki-67 as Predictive Biomarkers Identify Patients Who Will Be More Sensitive to Intravesical Instillations for the Prevention of Bladder Cancer Recurrence after Radical NephroureterectomyBladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets.Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder.Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer.Immunogenic FEAT protein circulates in the bloodstream of cancer patientsStatistical tests for clonality.Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.Comparison of properties of tests for assessing tumor clonality.Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours.DNA methylation accumulation and its predetermination of future cancer phenotypes.CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer.Combined cytotoxic effect of UV-irradiation and TiO2 microbeads in normal urothelial cells, low-grade and high-grade urothelial cancer cells.The role of laparoscopy-assisted renal autotransplantation in the treatment of primary ureteral tumor.Apparent diffusion coefficient on magnetic resonance imaging (MRI) in bladder cancer: relations with recurrence/progression risk.Preoperative positive urine cytology is a risk factor for subsequent development of bladder cancer after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.Non-invasive papillary urothelial carcinoma of the vagina: molecular analysis of a rare case identifies clonal relationship to non-invasive urothelial carcinoma of the bladder.An evolutionary perspective on field cancerization.Imaging-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model.Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.Bladder cancer.A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response.Evaluation of Intraoperative Versus Postoperative Adjuvant Mitomycin C with Nephroureterectomy for Urothelial Carcinoma of the Upper Urinary Tract
P2860
Q24793049-67C6D944-0AB3-4BF5-8805-A8B84A705A41Q33347849-36D552A7-3D7D-48B1-B304-D3B9617CB814Q33537302-EC874A92-64F5-4383-A5E9-C4BD6D6E2E58Q34121078-564CFF70-C46A-4CC6-B3BD-30100635C6B0Q34441297-624FCFFF-6734-4CD1-8CE8-2D6FCB11B55BQ34594334-8F609141-ACCD-4D50-B3D1-251EA24A1B52Q35016935-3D9F5104-0895-4D5A-90B1-7BB90B50A498Q35036964-044D7334-7BC2-4B0E-A49D-A083911AEF0EQ35629317-12C7A219-437E-41F8-9118-0B1217B83BDEQ35993380-37BBF085-9038-40A8-A06E-F10CAF010225Q36095721-BE7F0A48-1C3A-4E70-9784-6B308772C5FCQ36199792-330A1691-B44F-4B04-858D-176988E89B8FQ36334889-15E3B8BB-1F84-4271-906F-EB83D195732CQ36341182-E644F669-CB11-402C-8459-9D0166D192FEQ37152820-CADD6F3A-D01A-4D7F-A3F8-B999980F79C5Q37227743-A787A460-F22D-414D-B04C-5961F3BA54A4Q37278778-99F87E6C-9FB9-40FF-94D4-3BAF7EEED342Q37328954-94FD7669-4305-4144-A68E-BC8FA3AC0BBFQ37351010-589FB2B5-0B75-4B78-81A0-013072B15F63Q37385305-97A307E6-A41B-40F8-92BF-FFC8B00F3185Q38044251-33710BC7-6D82-4BB0-8B88-96DACC1C81B5Q38223048-C519DBCE-2158-47F5-A1F8-67DD949E7418Q38743011-89FD9152-8F13-4000-946E-35E26C61E6B0Q38941392-5F3F6A33-0FF1-435D-89F1-C22C31298777Q39198521-C2CE29E2-EE15-41ED-86B5-C69C6A5C5A10Q41129219-F2D102B9-B4C3-4C13-87F5-9A2AEEA93B3CQ45349485-4BD0E4FB-C0AC-4E31-B6A9-62F42F0B925BQ47738905-1502EA5A-7C78-483D-B247-AFCDCEEBDD0CQ50020845-08C4B063-9191-47D7-9B4F-983A22FF8A54Q50113746-7CCBEA9B-15C2-4D10-BEB9-4FC482546935Q51100757-D34D825F-85B7-4ED1-9C8C-ADF1EC6180B1Q52810295-02333750-FED6-4841-BC46-9244810FC539Q54487776-8A949BF2-DB61-4232-BA54-D3C3181786D0Q58705116-D607F91B-0764-48C3-AFD8-9108A0ED55F0
P2860
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.
@ast
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.
@en
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.
@nl
type
label
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.
@ast
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.
@en
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.
@nl
prefLabel
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.
@ast
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.
@en
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.
@nl
P2093
P2860
P356
P1476
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.
@en
P2093
Arndt Hartmann
Christian Hafner
Robert Stoehr
P2860
P356
10.1002/IJC.10544
P577
2002-09-01T00:00:00Z